💰NIH Closed Meetings Announce Grant Opportunities for Businesses
The National Institutes of Health announces closed meetings to review and evaluate grant applications, focusing on various scientific and research committees. These meetings are crucial for businesses seeking funding and support in the healthcare and biotechnology sectors.
Learn More📊CDC Seeks Comments on Suicide Prevention Program Information Collection
The CDC submitted a request for information collection regarding the Performance Monitoring of its Comprehensive Suicide Prevention Program. This includes gathering data to enhance reporting on suicide trends and to ensure program effectiveness. Stakeholders and agencies are invited to comment on the proposed changes within a specified period.
Learn More💰NIH Closed Meetings for Grant Applications – Business Funding Opportunities
This notice informs of upcoming closed meetings held by the NIH's Center for Scientific Review to evaluate grant applications. The meetings are virtual and focus on various biomedical fields, offering potential applicants insights into future funding opportunities and grant evaluation processes. Contact details for scientific review officers are also provided for further inquiries.
Learn More💰Intent to Award $4.5M Replacement Grant to Catholic Charities USA
The ACF, ORR, Division of Refugee Services (DRS) announces the intent to award a replacement cooperative agreement in the amount of up to $4,500,000 to Catholic Charities USA in Alexandria, VA.
Learn More🚬FDA's Information Collection on Tobacco Development Meetings
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Learn More💼NIH Center for Scientific Review
The NIH announces several closed meetings for grant evaluations by the Center for Scientific Review. These sessions are scheduled to assess various grant applications relevant to health and neuroscience. The meetings will occur virtually, ensuring engagement in the review process while safeguarding sensitive information. Contact details for specific committees and officers are provided for further inquiries.
Learn More💰Center for Scientific Review Notice on NIH Grant Evaluation Meetings
The Department of Health and Human Services, through the National Institutes of Health, announces closed meetings to review grant applications for diverse research projects. The meetings will facilitate evaluations of funding opportunities within various scientific domains, ensuring the confidentiality of discussions regarding sensitive information.
Learn More💰NIH Grants Review Meetings
The Department of Health and Human Services announces closed meetings of the Center for Scientific Review to evaluate various grant applications, including significant programs for small businesses involved in health research and development. These meetings focus on confidential discussions that aim to foster innovation and support funding initiatives in the industry.
Learn More⚖️FDA Debarment Order on William Goldsmith
The Food and Drug Administration (FDA) is issuing an order under the Federal Food, Drug, and Cosmetic Act (the FD&C Act) debarring William Goldsmith for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Goldsmith was convicted of one felony count under Federal law for introducing misbranded drugs into interstate commerce. The factual basis supporting Mr. Goldsmith's conviction, as described below, is conduct relating to the importation of a drug into the United States. Mr. Goldsmith was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of August 19, 2025 (more than 30 days after receipt of the notice), Mr. Goldsmith had not responded. Mr. Goldsmith's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.
Learn More💉FDA Regulation Vacatur and Its Impact on Laboratory Developed Tests
On May 6, 2024, the Food and Drug Administration (FDA, the Agency, or we) issued a final rule amending the definition of "in vitro diagnostic products" in FDA's regulations. On March 31, 2025, a federal district court vacated that rule. This final rule reverts to the text of the regulation as it existed prior to the effective date of the May 2024 final rule.
Learn More